139
Direct oral anticoagulants reduce time to direct current cardioversion over a 5 year period

EP Europace Journal

10 October 2018

Organised by:

Read full article

Contributors

Thompson Terri

Thompson Terri

Author

D Price

D Price

Author

P W X Foley

P W X Foley

Author

You may be interested in

Congress Presentation

One-year outcomes of inappropriate DOAC dosing in patients with atrial fibrillation

21 March 2026

Congress Presentation

Comparison of two DCCV algorithms - rational versus maximum fixed energy (PROTOCOLENERGY trial)

8 April 2024

Congress Presentation

Incidence and predictors of left atrial appendage thrombus on transoesophageal echocardiography before elective cardioversion

27 August 2021

Congress Presentation

Direct oral anticoagulants compared to vitamin K-antagonists in patients with left ventricular thrombus

27 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources